---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-133647"
form_type: "8-K"
ticker: "ACLS"
cik: "0001113232"
company_name: "AXCELIS TECHNOLOGIES INC"
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T13:42:26.359211+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Axcelis Q3 revenue $176.7M, record implant systems; EPS $0.81, guides Q4 EPS $0.84

## Summary
- Revenue $176.7M, up 20% QoQ; system revenue record $126.2M.
- Net income $27.5M ($0.81 diluted EPS) vs $18.9M ($0.55) Q2.
- Gross margin 43.3%, slightly down from 43.5% Q2.
- Q4 outlook: revenue ~$190M, EPS ~$0.84; FY 2021 revenue >$640M.
- Shipped Purion SiC and high-current implanters to Asia/Europe and memory customers.

## SEC filing metadata
- accession: 0001104659-21-133647
- form_type: 8-K
- ticker: ACLS
- cik: 0001113232
- company_name: AXCELIS TECHNOLOGIES INC
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1113232/000110465921133647/0001104659-21-133647-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1113232/000110465921133647/tm2131675d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-133647
- JSON: https://secwatch.observer/filing/0001104659-21-133647.json
- Plain text: https://secwatch.observer/filing/0001104659-21-133647.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.